New virtual, innovative clinical trial for adults at high risk for respiratory illnesses
Kaiser Permanente researchers to study Vascepa in people 50 and older with heart disease.
Kaiser Permanente conducts innovative, translational research that is an integral part of our social mission and essential to providing members with quality health care.